Want to join the conversation?
$VRTX said that the FDA has rejected its supplemental New Drug Application for the use of KALYDECO (ivacaftor) in people with cystic fibrosis ages two and older with one of 23 residual function mutations in the cystic fibrosis transmembrane conductance regulator gene. $VRTX plans to meet with the FDA to determine an appropriate path forward.
Can you imagine a food store with no cash registers? Well, it is coming true soon thanks to $AMZN. The company is opening its new grocery store in Seattle and it has no cash registers. AI takes over!
$AVGO reports 4Q earnings today. I am wondering what to expect.
$SHLD seems to be rolling down the curve, it has been reporting net loss for the past many quarters. The Company Board seems to be doing nothing to stem this trend.